Published Mar 20, 2015
Blacksburg, VA, USA – When vaccines are in short supply, public health officials must decide who among the public should be protected against disease – a decision that can hold moral and ethical implications. In order to avoid such concerns, objective methods should be put in place. Researchers at Virginia Tech devised a general framework that will provide objective ways of measuring the efficiency and fairness of public health intervention policies. To test the framework, the researchers simulated a number of vaccine strategies on a synthetic population representative of Montgomery County, Virginia, for an influenza-like outbreak. An SEIR (Susceptible, Exposed, Infected and Recovered) model was used to represent the progression of health states within the host. Many different axioms of fairness were considered to ensure coverage of realistic policy options. The results of the study showed that giving priority to the youngest members of large families leads to a better outcome when containing the spread of influenza. “Efficiency may not always be the end-all strategy when it comes to designing effective vaccine allocation. Fairness can play an important role when distributing medical resources, but up until now this measure of fairness has been rather subjective,” says Achla Marathe, PhD, Professor of Agricultural and Applied Economics at the Virginia Bioinformatics Institute at Virginia Tech, and author of the study. "To achieve an objective public health plan, it is important to consider both fairness and efficiency of intervention policies," says Molly O'Dell, MD, Director of the New River Health District at the Virginia Department of Health, and Adjunct Professor of Population Health sciences at Virginia Tech. The full study, “Fairness versus Efficiency of Vaccine Allocation Strategies,” is published in Value in Health.

Related Stories

Measuring What Matters: Broadening the Scope of Health Economics Evaluation to Incorporate Well-Being

Jul 9, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health that offer insights into facets of economic evaluation aimed to incorporate well-being into decision making.

Confronting the Backlash Against QALYs: Key Insights From Leading Health Economists

Jun 18, 2024

ISPOR announced the publication of a collection of papers that examine the long-standing debate surrounding the use of quality-adjusted life years (QALYs) and alternative measures in healthcare decision making.

ISPOR Good Practices Report Offers Guidance for Using Real-World Data From EHRs in Health Technology Assessments

Jun 17, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that proposes a framework for assessing the suitability of electronic health records data for use in health technology assessments. The report, “Assessing Real-World Data from Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force” was published in the June 2024 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now